Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Aptevo Therapeutics Inc. (APVO) had Stock-Based Compensation of $0.18M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.41M |
|
-- |
|
-- |
|
$6.48M |
|
$-6.48M |
|
$0.07M |
|
$-6.41M |
|
$-6.41M |
|
$-6.41M |
|
$-6.41M |
|
$-6.41M |
|
$-6.41M |
|
$-6.48M |
|
$-6.42M |
|
0.07M |
|
0.07M |
|
$-87.80 |
|
$-87.80 |
|
| Balance Sheet Financials | |
$3.61M |
|
$0.48M |
|
$4.74M |
|
$8.34M |
|
$5.39M |
|
-- |
|
$4.42M |
|
$9.81M |
|
$-1.47M |
|
$-1.47M |
|
$-1.47M |
|
0.07M |
|
| Cash Flow Statement Financials | |
$-6.58M |
|
-- |
|
-- |
|
$8.71M |
|
$2.14M |
|
$-6.58M |
|
|
Stock-Based Compensation |
$0.18M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
435.03% |
|
435.03% |
|
-76.82% |
|
435.03% |
|
$-20.19 |
|
$-90.19 |
|
$-90.19 |
|